National Venture Capital
200 Massachusetts Avenue NW Suite 520, Washington, DC, 20001, United States
Overview
The National Venture Capital Association is the premier trade association representing the venture capital industry in the United States. It aims to increase understanding of the importance of venture capital to the US economy and to encourage entrepreneurial activity and innovation. The NVCA represents the venture capital community's public policy interests, strives to maintain high professional standards, provides dependable industry data, sponsors professional development, and facilitates interaction among its members.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Association
- Financial Services
- Social Impact
- Venture Capital
Investment portfolio
- Nephron Pharmaceuticals
Led · Equity · Sep 2023
Nephron Pharmaceuticals develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates a 503B Outsourcing Facility that produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America. Led by CEO Lou Kennedy, Nephron supplies hospitals and healthcare providers with sterile injectable and inhalation therapies. The company raised $350M in funding and intends to use the proceeds to support future growth. Nephron is based in West Columbia, South Carolina, and focuses on expanding its pharmaceutical manufacturing and outsourcing capabilities.
- Microvast
Participated · Equity · Apr 2017
Microvast Power System is a vertically integrated developer and manufacturer of advanced electric vehicle power system solutions built on Microvast’s fast-charging, long-life, non-flammable Li-ion battery systems. The company reports its battery systems are operating in more than 15,000 electric and hybrid-electric vehicles across over 140 cities and has demonstrated high standards in public transport in major cities. MPS plans to launch products with higher energy density this year. In March it began construction on a Phase III production facility in Huzhou, Zhejiang, China, targeting 11 GWh of capacity in Phase III and 15 GWh total. The plant is expected to be in operation by 2019. The company recently received $400M in funding led by CITIC Securities.